AXODEV SARL

About AXODEV SARL

Thierry Paper is a well-known figure in the governance of BIOSYNEX, the French in vitro diagnostics and medtech company, where he serves as Deputy Chief Executive Officer and board member. He is also the manager of AXODEV SARL, a company closely connected to the group’s shareholder and operational ecosystem. BIOSYNEX corporate disclosures confirm that AXODEV has been involved in regulated-party agreements with the company, including service-fee arrangements, which underlines Paper’s long-standing role in supporting the group. His professional background is strongly anchored in healthcare technology. Public sources identify him as a founder of BIOSYNEX, which was established in 2005 and grew into a recognized player in rapid diagnostic tests, screening solutions, and prevention-oriented medical devices. His career combines industrial know-how, commercial development, and capital-structure management, reflecting experience across the main levers that shape a listed healthcare company’s trajectory. Within BIOSYNEX, Paper has played a key role in strategic and corporate matters. Recent shareholder meetings show that the company has regularly reviewed and approved conventions with AXODEV, indicating a formalized and ongoing relationship between the two entities. Financial communications and governance documents also highlight his involvement in capital structure matters and major financing decisions, including share capital increases designed to reinforce the company’s balance-sheet flexibility. From an expertise standpoint, Thierry Paper stands out for his understanding of medical devices, rapid diagnostic technologies, B2B distribution channels, and the specific governance demands of a listed healthcare business. His dual role at AXODEV and BIOSYNEX reflects an ability to connect governance, operational performance, and shareholder relations. Overall, his contribution is associated with long-term value creation and with a consistent presence in the company’s key structural and strategic decisions.